Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04380415 · ClinicalTrials.gov registry record · NA
Validation of Software for Assessment of Atrial Fibrillation From PPG Data Acquired by a Wearable Smartwatch
A NA study, sponsored by Fitbit.
- Completed
- Registry status
- NA
- Development phase
- 450,000
- Enrollment target
NCT04380415 is a NA study that has completed, run by Fitbit. The registered enrollment target is 450,000 participants.
The verdict
NCT04380415, a NA study, has completed, sponsored by Fitbit.
- COMPLETED
- Registry status
- NA
- Development phase
- 450,000 participants
- Enrollment target
Study Summary
Validate the Fitbit PPG RhythmDetect Software System algorithm for providing notifications by identifying rhythms suggestive of atrial fibrillation or atrial flutter events.
Interventions
- DIAGNOSTIC_TEST Single lead ambulatory ECG patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450,000 participants |
| Start Date | 2020-05-06 |
| Est. Completion | 2021-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04380415
The ClinicalTrials.gov registry entry for NCT04380415 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 450,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fitbit, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Single lead ambulatory ECG patch is the first listed.
NCT04380415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04380415 about?
NCT04380415 is a clinical study titled "Validation of Software for Assessment of Atrial Fibrillation From PPG Data Acquired by a Wearable Smartwatch". Validate the Fitbit PPG RhythmDetect Software System algorithm for providing notifications by identifying rhythms suggestive of atrial fibrillation or atrial flutter events.
What is the current status of trial NCT04380415?
This trial is currently completed. It is a NA study. The enrollment target is 450,000 participants. The study started on 2020-05-06. Estimated completion is 2021-03-08.
What interventions are being tested in trial NCT04380415?
The interventions under investigation include: Single lead ambulatory ECG patch (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04380415?
This trial is sponsored by Fitbit, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.